The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

Holiday photoshoots using popular characters like Dr. Seuss' The Grinch could be subject to copyright infringement lawsuits.

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Let's check out this ultimate pharma stock to buy now. Both drugs are based on the same molecule -- tirzepatide -- but Mounjaro is approved for type 2 diabetes, and Zepbound is approved for weight ...

I'm talking about Eli Lilly (NYSE: LLY), maker of Mounjaro and Zepbound. Both drugs are based on the same molecule — tirzepatide — but Mounjaro is approved for type 2 diabetes, and Zepbound is ...

Celebrities who have taken semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have experienced both health benefits and difficulties on the trendy drugs. GLP-1 drugs, once ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home, March 1, 2024, in ...

Learn how to get Mounjaro, a prescription medication used to treat diabetes and weight loss in eligible people. Here’s what to know about whether you might qualify, how much it costs ...

Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of Mounjaro and Zepbound, has also secured approval for its obesity treatments in the country, but has yet to launch them.